AXP107-11

· Axcentua Pharmaceuticals AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXP107-11, covering 2014-04-23 to 2014-04-23. Get the full timeline:

Most recent: Clinical Trial Update: AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer [Phase 1, Phase 2]

See pricing